344860 — Innogene Co Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩26bn
- KR₩25bn
- KR₩10bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Interim Report | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | — | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -412 | 790 | 2,258 | 1,339 | 1,396 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 524 | 450 | 132 | 197 | 164 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 56.4 | -676 | -435 | -1,175 | 460 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 431 | 802 | 2,185 | 597 | 2,251 |
Capital Expenditures | -12.1 | -15.1 | -4.81 | -34.4 | -47.8 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 44.4 | 30.3 | -1,500 | -366 | -10,023 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 32.3 | 15.2 | -1,505 | -401 | -10,071 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -132 | -568 | -83.7 | -111 | 7,729 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 331 | 249 | 597 | 84.6 | -91.3 |